Rxcurve
HCPCS J0893 · per 1 MG

Inj, decitabine (sun pharma)

This code is not in the latest file (4Q26). It was last listed in 1Q26.

Payment limit per 1 MG, by effective quarter, 1Q23 to 1Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0893

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
1Q26 $0.777 $0.00 1 MG Inj, decitabine (sun pharma) v1, posted September 15, 2026
4Q25 $0.777 $0.00 1 MG Inj, decitabine (sun pharma) v1, posted September 8, 2026
3Q25 $0.777 $0.00 1 MG Inj, decitabine (sun pharma) v1, posted March 10, 2026
2Q25 $0.777 – 1 MG Inj, decitabine (sun pharma) v1, posted March 10, 2026
1Q24 $0.777 −$1.343 1 MG Inj, decitabine (sun pharma) v1, posted December 19, 2024
4Q23 $2.12 −$0.12 1 MG Inj, decitabine (sun pharma) v1, posted October 10, 2024
3Q23 $2.24 +$0.359 1 MG Inj, decitabine (sun pharma) v1, posted June 5, 2024
2Q23 $1.881 +$0.305 1 MG Inj, decitabine (sun pharma) v1, posted February 23, 2024
1Q23 $1.576 – 1 MG Inj, decitabine (sun pharma) v1, posted December 6, 2023

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files